Last deal

$42.2M
Local Amount - JPY 6.B

Amount

Series A

Stage

17.07.2024

Date

1

all rounds

$42.2M

Total amount

General

About Company
Renalys Pharma is a private, late-stage clinical biopharmaceutical business in Japan focused on the discovery of novel medications.

founded date

2023

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.
Contacts